Protalix BioTherapeutics, Inc. (PLX) › Total AssetsProtalix BioTherapeutics, Inc. (PLX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $64.73M2011: $51.80M2012: $78.73M2013: $113.33M2014: $78.36M2015: $97.25M2016: $82.25M2017: $72.21M2018: $61.13M2019: $45.39M2020: $67.93M2021: $73.67M2022: $55.79M2023: $84.43M2024: $73.42M2025: $82.35M$82.35M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$82.35M+12.2%2024$73.42M-13.0%2023$84.43M+51.4%2022$55.79M-24.3%2021$73.67M+8.4%2020$67.93M+49.7%2019$45.39M-25.7%2018$61.13M-15.3%2017$72.21M-12.2%2016$82.25M-15.4%2015$97.25M+24.1%2014$78.36M-30.9%2013$113.33M+44.0%2012$78.73M+52.0%2011$51.80M-20.0%2010$64.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share